AMI Asset Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-1,408
Closed -$243K 72
2015
Q1
$243K Sell
1,408
-297,868
-100% -$43.7M 0.02% 66
2014
Q4
$34.4M Buy
299,276
+85,878
+40% +$10.4M 3.01% 8
2014
Q3
$33.3M Sell
213,398
-52,517
-20% -$7.61M 3.27% 2
2014
Q2
$32.8M Buy
265,915
+1,043
+0.4% +$115K 3.26% 3
2014
Q1
$27.4M Sell
264,872
-30,004
-10% -$3.07M 2.81% 10
2013
Q4
$26.5M Sell
294,876
-1,464
-0.5% -$117K 2.92% 11
2013
Q3
$19.8M Buy
296,340
+282,325
+2,014% +$19.5M 2.86% 19
2013
Q2
$927K Buy
+14,015
New +$801K 0.14% 52

Other funds holding SLXP

AMI Asset Management's SLXP Position: Q2 2015 in Review

AMI Asset Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,408 shares — an estimated $243K sold.

AMI Asset Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $34.4M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • AMI Asset Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • AMI Asset Management sold 1,408 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $243K.
  • AMI Asset Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • AMI Asset Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $34.4M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on AMI Asset Management's 13F filing for Q2 2015, filed 16 Jul 2015.